Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram-negative bacilli isolated from patients treated on surgical wards

Surgical Infections

Volumn 13, Issue 5, 2012, Pages 326-331

  Maraki, Sofia ^a   Mavros, Michael N ^b   Kofteridis, Diamantis P ^a,b   Samonis, George ^a   Falagas, Matthew E ^b,c,d  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c HENRY DUNANT HOSPITAL   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CILASTATIN PLUS IMIPENEM; COLISTIN; GENTAMICIN; MEROPENEM; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GREECE; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SURGERY DEPARTMENT, HOSPITAL;

EID: 84869742291     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.115     Document Type: Article

References (38)

1. Poulakou G, Giamarellou H. Investigational treatments for postoperative surgical site infections. Expert Opin Investig Drugs 2007;16:137-155. (Pubitemid 46206629)
2. Wallace WC, Cinat ME, Nastanski F, et al. New epidemiology for postoperative nosocomial infections. Am Surg 2000;66:874-878. (Pubitemid 30666937)
3. Neuhauser MM, Weinstein RA, Rydman R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use. JAMA 2003;289: 885-888. (Pubitemid 37430348)
4. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362:1804-1813.
5. Falagas ME, Siempos, II, Vardakas KZ. Linezolid versus glycopeptide or beta-lactam for treatment of gram-positive bacterial infections: Meta-analysis of randomised controlled trials. Lancet Infect Dis 2008;8:53-66. (Pubitemid 351620940)
6. Falagas ME, Giannopoulou KP, Ntziora F, Vardakas KZ. Daptomycin for endocarditis and/or bacteraemia: A systematic review of the experimental and clinical evidence. J Antimicrob Chemother 2007;60:7-19. (Pubitemid 47073272)
7. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
8. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gramnegative bacterial infections. Clin Infect Dis 2005;40:133-141.
9. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase-producing, Enterobacteriaceae infections: A systematic review. Lancet Infect Dis 2010;10:43-50.
10. Maraki S, Samonis G, Karageorgopoulos DE, et al. In vitro antimicrobial suscepibility to isepamicin of 6, 296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. Antimicrob Agents Chemother 2012;56:3067-30
11. Samonis G, Mareki S, Vouloumanou EK et al. Antimicrobial suscepibility of non-fermenting Gram-negative isolates to isepemicin in a region with high entibiotic resistance. Eur J Clin Microbiol Infect Dis 2012 July 1. [Epub ahead of print]
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Seventeenth informational supplement. Document M100-S20. Wayne, PA. The Institute. 2010.
13. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
14. Shi SH, Kong HS, Xu J, et al. Multidrug resistant gramnegative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009;11:405-412.
15. Baquero F, Hsueh PR, Paterson DL, et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect 2009; 10:99-104.
16. Toniolo A, Endimiani A, Luzzaro F. Microbiology of postoperative infections. Surg Infect 2006;7(Suppl 2):S13-S16.
17. Rodriguez CN, Rodriguez-Morales AJ, Garcia A, et al. Antimicrobial resistance of Pseudomonas aeruginosa strains isolated from surgical infections in a 7-year period at a general hospital in Venezuela. Surg Infect 2006;7:269-273. (Pubitemid 44193615)
18. Guggenheim M, Zbinden R, Handschin AE, et al. Changes in bacterial isolates from burn wounds and their antibiograms: A 20-year study (1986-2005). Burns 2009;35:553-560.
19. Johnson LE, D'Agata EM, Paterson DL, et al. Pseudomonas aeruginosa bacteremia over a 10-year period: Multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis 2009;11:227-234.
20. Mavros MN, Athanasiou S, Alexiou VG, et al. Risk factors for mesh-related infections after hernia repair surgery: A meta-analysis of cohort studies. World J Surg 2011;35:2389-2398.
21. Orrett FA. Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources. J Natl Med Assoc 2004;96:1065-1069. (Pubitemid 38971099)
22. Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of gram-negative pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 2010;66:2070-2074.
23. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-762.
24. Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2006;43(Suppl 2):S100-S105. (Pubitemid 44267148)
25. Kusachi S, Sumiyama Y, Arima Y, et al. Isolated bacteria and drug susceptibility associated with the course of surgical site infections. J Infect Chemother 2007;13:166-171. (Pubitemid 47012500)
26. Lautenbach E, Patel JB, Bilker WB, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-1171. (Pubitemid 32390110)
27. Samonis G, Matthaiou DK, Kofteridis D, et al. In vitro susceptibility to various antibiotics of colistin-resistant gramnegative bacterial isolates in a general tertiary hospital in Crete, Greece. Clin Infect Dis 2010;50:1689-1691.
28. Alexiou VG, Ierodiakonou V, Peppas G, Falagas ME. Antimicrobial prophylaxis in surgery: An international survey. Surg Infect 2010;11:343-348.
29. Tourmousoglou CE, Yiannakopoulou E, Kalapothaki V, et al. Adherence to guidelines for antibiotic prophylaxis in general surgery: A critical appraisal. J Antimicrob Chemother 2008;61:214-218.
30. Kritsotakis EI, Assithianakis P, Kanellos P, et al. Surveillance of monthly antimicrobial consumption rates stratified by patient-care area: A tool for triggering and targeting antibiotic policy changes in the hospital. J Chemother 2006; 18:394-401. (Pubitemid 44450021)
31. Roumbelaki M, Kritsotakis EI, Tsioutis C, et al. Surveillance of surgical site infections at a tertiary care hospital in Greece: Incidence, risk factors, microbiology, and impact. Am J Infect Control 2008;36:732-738.
32. Schnuriger B, Inaba K, Eberle BM, et al. Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. J Gastrointest Surg 2010;14:1304-1310.
33. Falagas ME, Alexiou VG, Peppas G, Makris GC. Do changes in antimicrobial resistance necessitate reconsideration of surgical antimicrobial prophylaxis strategies? Surg Infect 2009;10:557-562.
34. Bennett KM, Scarborough JE, Sharpe M, et al. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J Trauma 2007;63:307-311. (Pubitemid 47254639)
35. Kollef MH. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis 2006;43(Suppl 2):S82-S88. (Pubitemid 44267145)
36. de Smet AM, Kluytmans JA, Blok HE, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: An open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011;11:372-3780.
37. Pitsouni E, Alexiou V, Saridakis V, et al. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009; 65:561-570.
38. Flamm RK, Weaver MK, Thornsberry C, et al. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004;48:2431-2436. (Pubitemid 38823407)